Pericytes limit tumor cell metastasis

Journal of Clinical Investigation

Volumn 116, Issue 3, 2006, Pages 642-651

  Xian, Xiaojie ^a   Håkansson, Joakim ^b   Ståhlberg, Anders ^a   Lindblom, Per ^c   Betsholtz, Christer ^d   Gerhardt, Holger ^c   Semb, Henrik ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE CELL ADHESION MOLECULE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; CANCER GROWTH; CARCINOGENESIS; CELL INTERACTION; CONTROLLED STUDY; DISEASE MODEL; ENDOTHELIUM CELL; EPITHELIUM CELL; FIBROSARCOMA; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; MESENCHYME CELL; METASTASIS; MICROVASCULATURE; MOUSE; MOUSE STRAIN; NONHUMAN; PANCREAS ISLET CELL TUMOR; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SOLID TUMOR; TUMOR VASCULARIZATION; VASCULARIZATION;

ADENOMA, ISLET CELL; ANIMALS; CELL COMMUNICATION; ENDOTHELIUM, VASCULAR; FIBROSARCOMA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; NEURAL CELL ADHESION MOLECULES; PANCREATIC NEOPLASMS; PERICYTES;

EID: 33644643376     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI25705     Document Type: Article

References (46)

1. Ellis, L.M., and Fidler, I.J. 1996. Angiogenesis and metastasis. Eur. J. Cancer. 32A:2451-2460.
2. Thiery, J.P. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer. 2:442-454.
3. Hanahan, D. 1985. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature. 315:115-122.
4. Perl, A.K., et al. 1999. Reduced expression of neural cell adhesion molecule induces metastatic dissemination of pancreatic beta tumor cells. Nat. Med. 5:286-291.
5. Roesler, J., Srivatsan, E., Moatamed, F., Peters, J., and Livingston, E.H. 1997. Tumor suppressor activity of neural cell adhesion molecule in colon carcinoma. Am. J. Surg. 174:251-257.
6. Tezel, E., Kawase, Y., Takeda, S., Oshima, K., and Nakao, A. 2001. Expression of neural cell adhesion molecule in pancreatic cancer. Pancreas. 22:122-125.
7. Fogar, P., et al. 1997. Neural cell adhesion molecule (N-CAM) in gastrointestinal neoplasias. Anticancer Res. 17:1227-1230.
8. Allt, G., and Lawrenson, J.G. 2001. Pericytes: cell biology and pathology. Cells Tissues Organs. 169:1-11.
9. Armulik, A., Abramsson, A., and Betsholtz, C. 2005. Endothelial/pericyte interactions. Circ. Res. 97:512-523.
10. Baluk, P., Hashizume, H., and McDonald, D.M. 2005. Cellular abnormalities of blood vessels as targets in cancer. Curr. Opin. Genet. Dev. 15:102-111.
11. Abramsson, A., et al. 2002. Analysis of mural cell recruitment to tumor vessels. Circulation. 105:112-117.
12. Bergers, G., Song, S., Meyer-Morse, N., Bergsland, E., and Hanahan, D. 2003. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J. Clin. Invest. 111:1287-1295. doi:10.1172/JCI200317929.
13. Betsholtz, C., Karlsson, L., and Lindahl, P. 2001. Developmental roles of platelet-derived growth factors. Bioessays. 23:494-507.
14. Lindahl, P., et al. 1999. Role of platelet-derived growth factors in angiogenesis and alveogenesis. Curr. Top. Pathol. 93:27-33.
15. Lindahl, P., Johansson, B.R., Leveen, P., and Betsholtz, C. 1997. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science. 277:242-245.
16. Hashizume, H., et al. 2000. Openings between defective endothelial cells explain tumor vessel leakiness. Am. J. Pathol. 156:1363-1380.
17. Crnic, I., et al. 2004. Loss of neural cell adhesion molecule induces tumor metastasis by up-regulating lymphangiogenesis. Cancer Res. 64:8630-8638.
18. Morikawa, S., et al. 2002. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am. J. Pathol. 160:985-1000.
19. Rucker, H.K., Wynder, H.J., and Thomas, W.E. 2000. Cellular mechanisms of CNS pericytes. Brain Res. Bull. 51:363-369.
20. Tidhar, A., et al. 2001. A novel transgenic marker for migrating limb muscle precursors and for vascular smooth muscle cells. Dev. Dyn. 220:60-73.
21. Tallquist, M.D., French, W.J., and Soriano, P. 2003. Additive effects of PDGF receptor beta signaling pathways in vascular smooth muscle cell development. PLoS Biol. 1:E52.
22. Abramsson, A., Lindblom, P., and Betsholtz, C. 2003. Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. J. Clin. Invest. 112:1142-1151. doi:10.1172/JCI200318549.
23. Furuhashi, M., et al. 2004. Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate. Cancer Res. 64:2725-2733.
24. Hellstrom, M., et al. 2001. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J. Cell Biol. 153:543-553.
25. Hellstrom, M., Kalen, M., Lindahl, P., Abramsson, A., and Betsholtz, C. 1999. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development. 126:3047-3055.
26. Lindblom, P., et al. 2003. Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev. 17:1835-1840.
27. Taniguchi, S., et al. 2001. Structural fragility of blood vessels and peritoneum in calponin h1-deficient mice, resulting in an increase in hematogenous metastasis and peritoneal dissemination of malignant tumor cells. Cancer Res. 61:7627-7634.
28. Håkansson, J., et al. 2005. N-CAM-deficient beta cell tumorigenesis results in diminished ECM molecule expression and tumor cell-matrix adhesion. Tumor Biol. 26:103-112.
29. Jussila, L., and Alitalo, K. 2002. Vascular growth factors and lymphangiogenesis. Physiol. Rev. 82:673-700.
30. Pepper, M.S., and Skobe, M. 2003. Lymphatic endothelium: morphological, molecular and functional properties. J. Cell Biol. 163:209-213.
31. Mandriota, S.J., et al. 2001. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J. 20:672-682.
32. Ramaswamy, S., Ross, K.N., Lander, E.S., and Golub, T.R. 2003. A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33:49-54.
33. Liotta, L.A., and Kohn, E.C. 2001. The microenvironment of the tumour-host interface. Nature. 411:375-379.
34. Yonenaga, Y., et al. 2005. Absence of smooth muscle actin-positive pericyte coverage of tumor vessels correlates with hematogenous metastasis and prognosis of colorectal cancer patients. Oncology. 69:159-166.
35. Koganehira, Y., et al. 2003. Reduced expression of actin-binding proteins, h-caldesmon and calponin h1, in the vascular smooth muscle inside melanoma lesions: an adverse prognostic factor for malignant melanoma. Br. J. Dermatol. 148:971-980.
36. Schlingemann, R.O., et al. 1991. Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue. Am. J. Pathol. 138:1335-1347.
37. von Der Ohe, M., et al. 2002. Localization and characterization of polysialic acid-containing N-linked glycans from bovine NCAM. Glycobiology. 12:47-63.
38. Shimizu-Hirota, R., et al. 2004. Extracellular matrix glycoprotein biglycan enhances vascular smooth muscle cell proliferation and migration. Circ. Res. 94:1067-1074.
39. Jain, R.K. 2003. Molecular regulation of vessel maturation. Nat. Med. 9:685-693.
40. Jain, R.K. 2005. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science. 307:58-62.
41. Cremer, H., et al. 1994. Inactivation of the N-CAM gene in mice results in size reduction of the olfactory bulb and deficits in spatial learning. Nature. 367:455-459.
42. Shirayoshi, Y., Nose, A., Iwasaki, K., and Takeichi, M. 1986. N-linked oligosaccharides are not involved in the function of a cell-cell binding glycoprotein E-cadherin. Cell Struct. Funct. 11:245-252.
43. Enge, M., et al. 2002. Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy. EMBO J. 21:4307-4316.
44. Scheidl, S.J., et al. 2002. mRNA expression profiling of laser microbeam microdissected cells from slender embryonic structures. Am. J. Pathol. 160:801-813.
45. Stahlberg, A., Hakansson, J., Xian, X., Semb, H., and Kubista, M. 2004. Properties of the reverse transcription reaction in mRNA quantification. Clin. Chem. 50:509-515.
46. Stahlberg, A., Zoric, N., Aman, P., and Kubista, M. 2005. Quantitative real-time PCR for cancer detection: the lymphoma case. Expert Rev. Mol. Diagn. 5:221-230.